We therefore propose that CST1 may contribute to the dissociation of the CST3–CTSB complex by competitive heterodimeric CST1–CST3 binding, and CST1 would have beneficial effect to CRC patients. This evidence concerns the gene CST1 and colorectal carcinoma.